BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 28815730)

  • 1. Loss of BMI-1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4/MD-2/MyD88-mediated NF-κB signaling.
    Ye K; Chen QW; Sun YF; Lin JA; Xu JH
    J Cell Biochem; 2018 Feb; 119(2):1922-1930. PubMed ID: 28815730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro.
    Liu H; Zhang G; Huang J; Ma S; Mi K; Cheng J; Zhu Y; Zha X; Huang W
    J Transl Med; 2016 Apr; 14(1):104. PubMed ID: 27118139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-β2GPI/β2GPI stimulates activation of THP-1 cells through TLR4/MD-2/MyD88 and NF-κB signaling pathways.
    Zhou H; Sheng L; Wang H; Xie H; Mu Y; Wang T; Yan J
    Thromb Res; 2013; 132(6):742-9. PubMed ID: 24157085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway.
    Song J; Feng L; Zhong R; Xia Z; Zhang L; Cui L; Yan H; Jia X; Zhang Z
    Mol Carcinog; 2017 Jan; 56(1):36-48. PubMed ID: 26859114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes.
    Kong F; Ye B; Lin L; Cai X; Huang W; Huang Z
    Biomed Pharmacother; 2016 Aug; 82():167-72. PubMed ID: 27470352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
    Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
    Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavonoids from Radix Tetrastigmae inhibit TLR4/MD-2 mediated JNK and NF-κB pathway with anti-inflammatory properties.
    Liu D; Cao G; Han L; Ye Y; SiMa Y; Ge W
    Cytokine; 2016 Aug; 84():29-36. PubMed ID: 27235587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer.
    Nagaraju GP; Long TE; Park W; Landry JC; Taliaferro-Smith L; Farris AB; Diaz R; El-Rayes BF
    Mol Carcinog; 2015 Oct; 54(10):1147-58. PubMed ID: 24861206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid A3 binds MD-2 to activate p38 and NF-κB pathways in a MyD88-dependent manner.
    Deguchi A; Tomita T; Omori T; Komatsu A; Ohto U; Takahashi S; Tanimura N; Akashi-Takamura S; Miyake K; Maru Y
    J Immunol; 2013 Aug; 191(4):1856-64. PubMed ID: 23858030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the porcine alveolar macrophages via toll-like receptor 4/NF-κB mediated pathway provides a mechanism of resistin leading to inflammation.
    Li B; Fang J; Zuo Z; Yin S; He T; Yang M; Deng J; Shen L; Ma X; Yu S; Wang Y; Ren Z; Cui H
    Cytokine; 2018 Oct; 110():357-366. PubMed ID: 29655569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins.
    Li Z; Block MS; Vierkant RA; Fogarty ZC; Winham SJ; Visscher DW; Kalli KR; Wang C; Goode EL
    Tumour Biol; 2016 Oct; 37(10):13279-13286. PubMed ID: 27460076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of FSTL1 inhibits oxLDL-induced inflammation responses through the TLR4/MyD88/NF-κB and MAPK pathway.
    Guo J; Liang W; Li J; Long J
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1528-33. PubMed ID: 27569284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-410-3p activates the NF-κB pathway by targeting ZCCHC10 to promote migration, invasion and EMT of colorectal cancer.
    Ma ZH; Shi PD; Wan BS
    Cytokine; 2021 Apr; 140():155433. PubMed ID: 33517196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palmitate Activates CCL4 Expression in Human Monocytic Cells via TLR4/MyD88 Dependent Activation of NF-κB/MAPK/ PI3K Signaling Systems.
    Kochumon S; Wilson A; Chandy B; Shenouda S; Tuomilehto J; Sindhu S; Ahmad R
    Cell Physiol Biochem; 2018; 46(3):953-964. PubMed ID: 29669317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol.
    Buhrmann C; Yazdi M; Popper B; Kunnumakkara AB; Aggarwal BB; Shakibaei M
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30917533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
    Liu P; Li F; Qiu M; He L
    Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epimedium sagittatum inhibits TLR4/MD-2 mediated NF-κB signaling pathway with anti-inflammatory activity.
    Yan N; Wen DS; Zhao YR; Xu SJ
    BMC Complement Altern Med; 2018 Nov; 18(1):303. PubMed ID: 30424767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Uric Acid-Induced Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells via the TLR4/NF-kB Signaling Pathway.
    Liu H; Xiong J; He T; Xiao T; Li Y; Yu Y; Huang Y; Xu X; Huang Y; Zhang J; Zhang B; Zhao J
    Am J Nephrol; 2017; 46(4):333-342. PubMed ID: 29017152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sTLR4/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS.
    Zou Y; Qin F; Chen J; Meng J; Wei L; Wu C; Zhang Q; Wei D; Chen X; Wu H; Chen X; Dai S
    Oncotarget; 2016 Aug; 7(32):52032-52044. PubMed ID: 27409669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.